Weight Loss Pill Australia: Wegovy Tablets, Foundayo and Your Options in 2026

TL;DR: Australia now has two approved weight loss pills. The TGA registered Wegovy tablets (oral semaglutide) on 3 November 2026, with a recommended retail price of $260 to $395 a month and supply expected before the end of 2026. Foundayo (orforglipron) from Eli Lilly was approved on 16 November 2026 and is expected in pharmacies within days. Neither is on the PBS, and both need a doctor's prescription.

A weight loss pill is now a real option in Australia. In November 2026 the Therapeutic Goods Administration approved two once daily GLP 1 tablets for weight management, two weeks apart. Until then, every GLP 1 medicine for weight loss here came as an injection.

For many patients, that was the sticking point. Some people dislike needles, some travel often and struggle with pen storage, and some want to try a tablet before committing to a weekly injection.

This guide explains what has been approved, how the two pills differ, how they compare with injections, and what they cost. Our pharmacist team wrote it for education, and it is not personal medical advice. Whether any of these medicines suits you is a decision for a registered doctor as part of a medically supervised weight loss plan.

Is There a Weight Loss Pill Approved in Australia?

Yes, there are two. The TGA registered Wegovy tablets (oral semaglutide) on 3 November 2026 and Foundayo (orforglipron) on 16 November 2026, both for chronic weight management in eligible adults. Both are prescription only medicines, and neither is subsidised on the PBS for weight loss.

Approval does not mean instant supply. According to ABC News, the TGA still checks packaging and production before a new medicine is released. Lilly expects Foundayo to be available within days of its approval, as reported by The Nightly, while Novo Nordisk is aiming for Wegovy tablets before the end of 2026.

Both tablets are approved for use alongside a reduced calorie diet and more physical activity, the same as the injections.

What Are Wegovy Tablets, and How Much Do They Cost?

Wegovy tablets contain semaglutide, the same active ingredient as the weekly Wegovy injection, in a once daily tablet. Novo Nordisk has set a recommended retail price of $260 to $395 a month, depending on the dose, according to the Australian Financial Review. No launch date has been confirmed.

The TGA registered four strengths: 1.5 mg, 4 mg, 9 mg and 25 mg, as 1News reported. Treatment starts low and steps up. Under the United States label, the dose begins at 1.5 mg and increases every 30 days towards 25 mg daily, as summarised by DietGLP.

The tablet is swallowed each morning on an empty stomach, as reported by The Nightly. Semaglutide tablets absorb poorly when taken with food, so timing matters. Your pharmacist will go through the exact instructions when it is dispensed.

In the OASIS 4 trial, adults taking 25 mg once daily lost an average of 16.6% of their body weight when they took it as directed, according to Novo Nordisk's announcement of its United States approval. Novo Nordisk describes this as similar to the Wegovy 2.4 mg injection.

Pharmacies set their own final prices, so what you pay can differ from the recommended price. For injection costs by dose, see our Wegovy cost guide.

What Is Foundayo (Orforglipron), and When Can You Get It?

Foundayo is the brand name for orforglipron, a once daily GLP 1 tablet made by Eli Lilly. It was entered on the Australian Register of Therapeutic Goods on 16 November 2026 for weight management and for type 2 diabetes, according to an ARTG summary by AskMyGP. Lilly has not published an Australian price.

Unlike semaglutide tablets, orforglipron is a small molecule. Lilly Australia says it can be taken at any time of day without food or water restrictions, as reported by The Nightly. That makes it simpler to fit into a routine than a tablet that needs an empty stomach.

In the ATTAIN 1 trial, people on the highest dose who stayed on treatment lost an average of 12.4% of their body weight, according to Pharmaceutical Technology. Across everyone who started the highest dose, the average was about 11%, as the Associated Press reported.

Lilly Australia's safety information says Foundayo is not recommended together with other GLP 1 medicines, should not be used in pregnancy, and can cause low blood sugar when combined with insulin or a sulfonylurea (The Nightly). The Australian Product Information had not been published at the time of writing, so your doctor and pharmacist will guide you on dosing.

Foundayo was approved in the United States in April 2026. Australian approval means a doctor can now prescribe it on a private script. Products sold online as "orforglipron" without a prescription, or from outside the regulated supply chain, are not the approved medicine.

Weight Loss Pills vs Injections: How Do They Compare?

Weight loss tablets offer daily dosing without needles, while injections are taken once a week. In clinical trials, the injections produced somewhat larger average weight loss, although no trial has compared all four medicines head to head.

MedicineHow it is takenAverage weight loss in its main trialsAustralian status (November 2026)
Wegovy tablets (semaglutide)Once daily tablet, empty stomach16.6% when taken as directed (OASIS 4)TGA approved 3 Nov 2026; recommended price $260 to $395 a month; not yet in pharmacies
Foundayo (orforglipron)Once daily tablet, no food rules12.4% at the highest dose for people who stayed on treatment (ATTAIN 1)TGA approved 16 Nov 2026; stock expected within days; no published price
Wegovy injection (semaglutide)Once weekly injectionAbout 15%Private prescription
Mounjaro injection (tirzepatide)Once weekly injectionAbout 21%Private prescription

Injection figures come from the Associated Press summary of the trials. Each medicine was tested in a different trial, so the numbers are a guide rather than a ranking.

Side effects are similar across the class. Nausea, vomiting, diarrhoea and constipation are the most common, especially when a dose first increases.

The right choice depends on your health history, other medicines, budget and whether you can keep to a daily routine. For a closer look at the two injections, read our Mounjaro vs Wegovy guide.

Which Other Weight Loss Tablets Can Australians Get?

Before the GLP 1 tablets, the weight loss tablets available on prescription in Australia were older medicines that work differently. A doctor may still consider them when GLP 1 medicines are not suitable or not affordable.

Contrave combines naltrexone and bupropion in a tablet that acts on appetite and cravings. Our Contrave cost guide covers pricing, side effects and who it suits.

Phentermine is a short term appetite suppressant taken as a capsule, with strict prescribing rules. Our phentermine guide explains brands, cost and how prescribing works.

Neither is a GLP 1 medicine, and both carry their own safety checks. To compare every option by monthly cost, see our guide to the cheapest weight loss medication in Australia.

Are Weight Loss Pills on the PBS?

No. Neither Wegovy tablets nor Foundayo is on the PBS for weight management, so you pay the private price. For Wegovy tablets that is a recommended $260 to $395 a month, and Lilly has not yet published a price for Foundayo.

Under current rules, the PBS subsidises GLP 1 medicines only for people with type 2 diabetes, as ABC News reported. No orforglipron submission appears on published PBAC agendas, including the November 2026 meeting, according to AskMyGP.

The injections show how slow subsidy can be. A revised proposal for a narrow Wegovy injection listing went to the November 2026 PBAC meeting, with outcomes due on 18 December 2026, according to the PBS medicine status page. Our Wegovy PBS status article tracks it.

For Mounjaro, the PBS medicine status page confirms that Eli Lilly is not proceeding with a type 2 diabetes listing. Our Mounjaro cost guide shows what patients pay instead.

How Do You Get a Prescription for a Weight Loss Pill?

Both tablets are prescription only, so the pathway starts with a doctor. It is the same process used for weight loss injections today:

  1. See a doctor. Book a GP or telehealth consultation, where a registered doctor reviews your weight history, health conditions and current medicines.

  2. Get an eScript if suitable. If treatment is clinically appropriate, your prescription is sent to your phone or email.

  3. Have it dispensed. A licensed Australian pharmacy dispenses it and explains how to take it, once stock is available.

Our guide to weight loss prescriptions online explains how telehealth assessment works.

If you already use a weight loss injection, do not stop it to switch to a tablet on your own. Changing medicines needs a plan from your doctor, including the right starting dose.

Be wary of online sellers. Copies of these medicines sold without a prescription, or made outside the regulated supply chain, carry real safety risks. Our article on why tirzepatide cannot be compounded explains the rules that apply to these medicines.

What This Means for You

Three facts sum up weight loss pills in Australia right now. Two GLP 1 tablets are approved: Wegovy tablets and Foundayo. Foundayo is expected first, and Wegovy tablets have a recommended price of $260 to $395 a month. Neither is subsidised by the PBS.

If a daily tablet appeals to you, start with a conversation with a doctor about whether GLP 1 treatment suits you at all. Your health history, other medicines and budget will decide which option fits.

Our pharmacists can answer your questions about weight loss tablets and injections. Call us on 03 8204 6600 or book a consultation with our telehealth partner.

Frequently Asked Questions

Is there a weight loss pill approved in Australia?

Yes, two. The TGA approved Wegovy tablets (oral semaglutide) on 3 November 2026 and Foundayo (orforglipron) on 16 November 2026 for weight management. Both are prescription only and not subsidised on the PBS for weight loss.

How much does the Wegovy pill cost in Australia?

Novo Nordisk has set a recommended retail price of $260 to $395 a month, depending on the dose. It is not on the PBS for weight management, so you pay the private price, and pharmacies may charge slightly different amounts.

Is Foundayo (orforglipron) available in Australia?

Foundayo was approved by the TGA on 16 November 2026, and Eli Lilly expects stock in pharmacies within days. You need a doctor's prescription. Lilly has not published an Australian price, and it is not on the PBS.

Do weight loss pills work as well as injections?

In clinical trials, average weight loss with the tablets was a little lower than with Mounjaro and close to the Wegovy injection. No trial has compared them all directly, and individual results vary. Your doctor will weigh the evidence against your health profile.

Can I buy weight loss pills online without a prescription?

No. Wegovy tablets, Foundayo, Contrave and phentermine are all prescription medicines in Australia. Products sold online without a prescription may be fake, contaminated or unapproved, so always use a registered doctor and a licensed Australian pharmacy.

This article is general information only and does not replace advice from your doctor or pharmacist. Wegovy, Foundayo, Mounjaro, Contrave and phentermine are prescription medicines. Read our General Medical Disclaimer. Information checked 18 November 2026.

Next
Next

Nicotine Patches in Australia: How They Work, How to Use Them and Side Effects